Finance

Beta
Lists
QNRX:NASDAQ
Quoin Pharmaceuticals Ltd - ADR
$4.77
-5.73%
(-0.29) 1D
Jun 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QNRX...
Open
$4.94
High
$5.00
Low
$4.68
Mkt. cap
9.58M
Avg. vol.
28.19K
Volume
31.00K
52-wk high
$41.80
52-wk low
$4.55
EPS
-$577.30
Beta
1.61
Shares outstanding
2.01M
No. of employees
5
Open
$4.94
High
$5.00
Low
$4.68
Mkt. cap
9.58M
Avg. vol.
28.19K
Volume
31.00K
52-wk high
$41.80
52-wk low
$4.55
EPS
-$577.30
Beta
1.61
Shares outstanding
2.01M
No. of employees
5
News stories
From sources across the web
About Quoin Pharmaceuticals Ltd - ADR
CEO-
Employees5
Founded1986
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.05M
2.28M
3.10M
3.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.74M
1.74M
1.42M
1.70M
Operating expense
3.79M
4.02M
4.52M
5.13M
Total operating expenses
3.79M
4.02M
4.52M
5.13M
Operating income
-3.79M
-4.02M
-4.52M
-5.13M
Other non operating income
-6.00K
9.49K
364.00
133.48K
EBT including unusual items
-3.70M
-3.95M
-4.35M
-5.00M
EBT excluding unusual items
-3.70M
-3.95M
-4.35M
-5.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.70M
-3.95M
-4.35M
-5.00M
Net profit margin
-
-
-
-
Earnings per share
-6.27
-6.70
-
-1.77
Interest and investment income
103.24K
62.27K
171.70K
-
Interest expense
-
-
-
-
Net interest expenses
103.24K
62.27K
171.70K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.77M
-3.99M
-4.50M
-5.11M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more